Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,571 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Failure to Launch: Why Some Generics Don't Take.
Scheckel CJ, Desai A, Rajkumar SV. Scheckel CJ, et al. Among authors: desai a. Mayo Clin Proc. 2022 Nov;97(11):1975-1980. doi: 10.1016/j.mayocp.2022.07.016. Mayo Clin Proc. 2022. PMID: 36333013 No abstract available.
Neulasta Onpro: a coup de grâce?
Jensen CJ, Scheckel CJ, Go RS, Desai A, Soefje SA. Jensen CJ, et al. Among authors: desai a. Am J Manag Care. 2023 Mar 1;29(3):e69-e70. doi: 10.37765/ajmc.2023.89331. Am J Manag Care. 2023. PMID: 36947018 Free article.
Real-World Outcomes With Lurbinectedin in Second-Line Setting and Beyond for Extensive Stage Small Cell Lung Cancer.
Desai A, Smith CJ, Ashara Y, Orme JJ, Zanwar S, Potter A, Hocum C, Moffett JN, Schwecke AJ, Manochakian R, Lou Y, Zhao Y, Ernani V, Savvides P, Molina J, Dimou A, Mansfield AS, Parikh K, Leventakos K. Desai A, et al. Clin Lung Cancer. 2023 Dec;24(8):689-695.e1. doi: 10.1016/j.cllc.2023.09.001. Epub 2023 Sep 17. Clin Lung Cancer. 2023. PMID: 37880074 Free article.
Antibody Drug Conjugates in Lung Cancer.
Merle G, Friedlaender A, Desai A, Addeo A. Merle G, et al. Among authors: desai a. Cancer J. 2022 Nov-Dec 01;28(6):429-435. doi: 10.1097/PPO.0000000000000630. Cancer J. 2022. PMID: 36383905 Review.
Time from immune checkpoint inhibitor to sotorasib use correlates with risk of hepatotoxicity in non-small cell lung cancer: A brief report.
Desai A, Rakshit S, Bansal R, Ashara Y, Potter A, Manochakian R, Lou Y, Zhao Y, Ernani V, Savvides P, Schwecke A, Moffett N, Hocum C, Leventakos K, Adjei A, Marks R, Molina J, Mansfield AS, Chen ZM, Dimou A. Desai A, et al. Cancer Treat Res Commun. 2023;36:100743. doi: 10.1016/j.ctarc.2023.100743. Epub 2023 Jul 13. Cancer Treat Res Commun. 2023. PMID: 37531736 Free article.
Immunotherapy-based combinations in metastatic NSCLC.
Desai A, Peters S. Desai A, et al. Cancer Treat Rev. 2023 May;116:102545. doi: 10.1016/j.ctrv.2023.102545. Epub 2023 Mar 27. Cancer Treat Rev. 2023. PMID: 37030062 Free article. Review.
3,571 results